Key result
Fetal exposure to anti-SSA/Ro and anti-SSB/La antibodies was associated with a significantly prolonged PQ segment on fetal magnetocardiography (P=0.007) without progression to advanced heart block.
Why the study?
Does exposure to anti-SSA/Ro and anti-SSB/La antibodies cause atrioventricular conduction delay in fetuses as measured by fetal magnetocardiography?
Observational (n=48)
Does exposure to anti-SSA/Ro and anti-SSB/La antibodies cause atrioventricular conduction delay in fetuses as measured by fetal magnetocardiography?
Fetal magnetocardiography identifies a low-risk population of fetuses exposed to maternal anti-SSA/Ro and anti-SSB/La antibodies who have PQ segment prolongation but do not progress to advanced heart block.
Identifies low-risk antibody-exposed fetuses with isolated PQ prolongation; leaves open optimal magnetocardiography use pending prospective validation.
BACKGROUND: The presence of anti-SSA/Ro and anti-SSB/La antibodies during pregnancy is associated with fetal congenital heart block (CHB), which is primarily diagnosed through fetal echocardiography. Conclusive information about the complete electrophysiology of the fetal cardiac conducting system is still lacking. In addition to echocardiography, fetal magnetocardiography (fMCG) can be used. fMCG is the magnetic analogue of the fetal electrocardiogram (ECG). PATIENTS AND METHODS: Forty-eight pregnant women were enrolled in an observational study; 16 of them tested positive for anti-SSA/Ro and anti-SSB/La antibodies. In addition to routine fetal echocardiography, fMCG was used. Fetal cardiac time intervals (fCTIs) were extracted from the magnetic recordings by predefined procedures. ECGs in the neonates of the study group were performed within the first month after delivery. RESULTS: The PQ segment of the fCTI was significantly prolonged in the study group (P = 0.007), representing a delay of the electrical impulse in the atrioventricular (AV) node. Other fCTIs were within normal range. None of the anti-SSA/Ro and/or anti-SSB/La fetuses progressed to a more advanced heart block during pregnancy or after birth. CONCLUSION: The study identified a low-risk population within antibody positive mothers, where PQ segment prolongation is associated with a lack of progression of the disease.
No takes yet. Share an insight, caveat, or question.
Wacker‐Gussmann et al. (2012) conducted an observational in Fetal congenital heart block risk (n=48). Anti-SSA/Ro and anti-SSB/La antibodies vs. Antibody negative pregnant women was evaluated on PQ segment of the fetal cardiac time intervals (p=0.007). Fetal exposure to anti-SSA/Ro and anti-SSB/La antibodies was associated with a significantly prolonged PQ segment on fetal magnetocardiography (P=0.007) without progression to advanced heart block.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: